Embecta Corp. (EMBC) Dividend History

Embecta Corp. (EMBC) is a global diabetes care company focused on providing innovative medical products and solutions. Originally part of Becton, Dickinson and Company (BD), Embecta became an independent entity specializing in diabetes management, including insulin delivery devices and related products. The company aims to improve the quality of life for individuals with diabetes through its portfolio of trusted, high-quality healthcare solutions.

1209 Orange Street, Wilmington, DE, 19801
Phone: (862) 401-0000
Website: https://www.embecta.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
June 13, 2025	$0.15	05/28/2025	05/28/2025
March 14, 2025	$0.15	02/28/2025	02/28/2025
December 18, 2024	$0.15	12/06/2024	12/06/2024
September 13, 2024	$0.15	08/27/2024	08/27/2024
June 14, 2024	$0.15	05/24/2024	05/28/2024
March 15, 2024	$0.15	02/27/2024	02/28/2024
December 15, 2023	$0.15	12/01/2023	12/04/2023
September 13, 2023	$0.15	08/24/2023	08/25/2023
June 13, 2023	$0.15	05/25/2023	05/29/2023
March 13, 2023	$0.15	02/24/2023	02/27/2023
January 11, 2023	$0.15	12/29/2022	12/30/2022
September 14, 2022	$0.15	08/25/2022	08/26/2022

Dividends Summary

Embecta Corp. has issued 12 dividend payments over the past 3 years
The most recent dividend was paid 86 days ago, on March 14, 2025
The first recorded dividend was paid on September 14, 2022
The highest dividend payout was $0.15 per share
The average dividend over this 3 year span is $0.15 per share

Company News

embecta to Participate in Investor Events

Embecta Corp., a global diabetes care company, reported its financial results for the second quarter of fiscal 2025. The company also announced its participation in various investor events.

GlobeNewswire Inc.
embecta Announces Quarterly Cash Dividend

Embecta Corp. (EMBC) has declared a quarterly cash dividend of $0.15 per share, payable on June 13, 2025 to stockholders of record as of May 28, 2025.

GlobeNewswire Inc.
embecta to Report Fiscal Second Quarter 2025 Financial Results

embecta Corp., a global diabetes care company, will host a conference call to discuss its fiscal second quarter 2025 financial results and provide an operational update on May 9, 2025.

GlobeNewswire Inc.
embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

embecta Corp., a global diabetes care company, announced that its Chief Financial Officer will present at the J.P. Morgan Global Leveraged Finance Conference on February 25, 2025.

GlobeNewswire Inc.
Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business

Becton Dickinson reported strong Q1 2025 results, with revenue and EPS beating estimates. However, the company lowered its fiscal year 2025 outlook and announced plans to separate its Biosciences and Diagnostic Solutions business by fiscal 2026.

Benzinga

Featured Companies: BDX

Dividend data last updated 06/08/2025 01:46:10 UTC